Biggest News Aggregation in the World
📰 Cortigent Inc News

Cortigent Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cortigent Inc. Real-time updates on events, politics, business and more.

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Vivani Medical, Inc. , an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic implants, announced today that its wholly-owned...
Los Angeles United States Ausaf Bari Drug Administration Vivani Medical Inc Nano Precision Medical Inc

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Vivani Medical, Inc. , an innovative, near clinical-stage biopharmaceutical company that develops novel, miniature, long-term therapeutic implants, announced today that Company CEO Adam Mendelsohn,... | June 14, 2023
Adam Mendelsohn Nano Precision Medical Inc Company Or Vivani Maxim Group Exchange Commission The Cortigent Inc

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Vivani Medical, Inc. , an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received notice from the National Institutes of Health ... | April 4, 2023
Los Angeles United States Vivani Medical Inc National Institutes Of Health Second Sight Medical Products Inc Neuromodulation Division

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment of patients with type 2 diab...
United States Adam Mendelsohn Bydureon Bcise Development Expense Exchange Commission The Biopharm Division

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science